News : 2013 : September

The UM/Jackson team helping Peru includes, from left, Silvia Willumsen, RN, BSN, Maria Cabello, RN, Julio C. Barredo, M.D., Martin Andreansky, M.D., Krishna Komanduri, M.D., Cara Benjamin, Ph.D., and Alexandra Amador, MT, CHS.

Sylvester/Jackson Team Launches Peru’s Pediatric Bone Marrow Transplant Unit

Extending Sylvester Comprehensive Cancer Center’s outreach to Peru, a University of Miami and Jackson Memorial Hospital team led by Julio C. Barredo, M.D., Director of Children’s Cancer Programs at Sylvester and the Toppel Family Chair in Pediatric Hematology-Oncology, recently conducted the initial training workshop for specialists who will operate Peru’s first comprehensive pediatric bone marrow transplant referral center.

Read more »

Maria Rodriguez, RN, left, and Elena E. Perez, M.D., Ph.D., stand outside the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at the Miller School.

Primary Immunodeficiencies Center Receives Continued Support to Advance Treatments

The Jeffrey Modell Foundation has renewed its partnership with the Miller School by continuing its support of the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies.

Read more »

Kathleen Vergara

Congratulations to our own Kathy Vergara.

Kathleen Vergara, Director of the Debbie School at UM Mailman Center for Child Development, has been selected to receive the ‘Excellence in Family Advocacy Award’ from Parent to Parent of Miami. She will be honored at their annual benefit gala “Journey of Dreams” on Friday Nov. 22, 2013.

Read more »

Crucial to the study were the Pediatric Cardiomyopathy Registry team members, from left, Samuel Ross, Miriam Mestre, study co-author Juanita Hunter, M.D., Danielle Dauphin; Principal Investigator Steven E. Lipshultz, M.D.,Candace Waithe-Boodoo, co-author James D. Wilkinson, M.D., M.P.H., and Joslyn Westphal.

Lancet Study Outlines First Risk Calculator for Pediatric Hypertrophic Cardiomyopathy

A decade-long quest to understand why some children with hypertrophic cardiomyopathy do well under medical management while others die of heart failure or sudden cardiac death showed certain infants are at highest risk for dismal outcomes and yielded a risk calculator cardiologists can use to evaluate which of them should be considered for a heart transplant immediately after diagnosis.

Read more »